Medical Innovation Exchange

Aptinyx, reeling from series of setbacks, dumps dementia drug, stops PTSD trial after phase 2 flop

https://www.fiercebiotech.com/biotech/aptinyx-reeling-series-setbacks-dumps-dementia-drug-stops-ptsd-trial-after-phase-2-flop

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!